Diproteverine

Diproteverine
Clinical data
ATC code	none;
Identifiers
	IUPAC name 1-[(3,4-diethoxyphenyl)methyl]-6,7-dipropan-2-; yloxy-3,4-dihydroisoquinoline;
CAS Number	69373-95-1 ; 69373-88-2 (hydrochloride);
PubChem CID	50463;
ChemSpider	45755 ;
UNII	8A5OIA91GT;
CompTox Dashboard (EPA)	DTXSID10219464 ;
Chemical and physical data
Formula	C26H35NO4
Molar mass	425.569 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O(c1ccc(cc1OCC)CC/2=N/CCc3cc(OC(C)C)c(OC(C)C)cc\23)CC;
	InChI InChI=1S/C26H35NO4/c1-7-28-23-10-9-19(14-24(23)29-8-2)13-22-21-16-26(31-18(5)6)25(30-17(3)4)15-20(21)11-12-27-22/h9-10,14-18H,7-8,11-13H2,1-6H3 ; Key:APMMVXSVJLZZRR-UHFFFAOYSA-N ;
	(verify)

Diproteverine (usually as diproteverine hydrochloride) is a calcium channel blocker.^[1]

References

^ Lacroix P, Linee P, Forest MC (January 1991). "Diproteverine (BRL 40015): a new type of calcium antagonist with potential antianginal properties". European Journal of Pharmacology. 192 (3): 317–27. doi:10.1016/0014-2999(91)90220-k. PMID 2055233.